The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.
Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders
Open accessAbstract
This paper proposes a heuristic framework for an Addictions Neuroclinical Assessment (ANA) that incorporates key functional domains derived from the neurocircuitry of addiction. We review how addictive disorders (AD) are presently diagnosed, and the need for new neuroclinical measures to differentiate patients who meet clinical criteria for addiction to the same agent while differing in etiology, prognosis and treatment response. The need for a better understanding of the mechanisms provoking and maintaining addiction, as evidenced by the limitations of current treatments and within-diagnosis clinical heterogeneity, is articulated. In addition, recent changes in the nosology of AD, challenges to current classification systems, and prior attempts to subtype individuals with AD are described. Complementary initiatives, including the Research Domain Criteria (RDoC) project, which have established frameworks for the neuroscience of psychiatric disorders, are discussed. Three domains, executive function, incentive salience, and negative emotionality, tied to different phases in the cycle of addiction, form the core functional elements of AD. Measurement of these domains in epidemiologic, genetic, clinical, and treatment studies will provide the underpinnings for an understanding of cross-population and temporal variation in addictions, shared mechanisms in addictive disorders, impact of changing environmental influences, and gene identification. Finally, we show that it is practical to implement such a deep neuroclinical assessment using a combination of neuroimaging and performance measures. Neuroclinical assessment is key to reconceptualizing the nosology of AD on the basis of process and etiology, an advance that can lead to improved prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Advances in diagnosis that reflect such an endophenotype or research domain criterion approach will synergistically combine with advances in neurobiology to promote novel pharmacotherapeutic, brain stimulation (ie, transcranial magnetic stimulation and direct electrical stimulation), and behavioural treatments.186”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [186]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the Addictions Neuroclinical Assessment, five subdomains of negative emotional states that can be operationally measured in human laboratory settings and paralleled by animal models were outlined (Kwako et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Kwako et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From a nosology perspective, the Addictions Neuroclinical Assessment framework allows the identification of individuals with phenotypes that signal dysregulation in this domain (Kwako et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Kwako et al., 2016
Experimental — accuracy not yet measuredIn the citing paper
“a neurofunctional domain that is postulated to be relevant to early onset of risky alcohol use and the development and maintenance of AUDs (15).”
From Impact of Childhood Trauma on Executive Function in Adolescence—Mediating Functional Brain Networks and Prediction of High-Risk Drinking (2020) · cites this paper as [15]
In the citing paper
“third, it integrates measures for an understanding of the overall functioning of a domain”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“The ANA domains, which encompass only a small fraction of the biomarker space for addiction, are incentive salience (see Glossary), negative emotionality, and executive function [2].”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“The ANA domains, which encompass only a small fraction of the biomarker space for addiction, are incentive salience (see Glossary), negative emotionality, and executive function [2].”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“fourth, it is a research approach for assessment of addiction, not capable, or intended to diagnose DSM-based alcohol/substance use disorders.”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
In the citing paper
“first, it targets measures towards domains that are mechanistically important”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067
Development and validation of a brief screening version of the Childhood Trauma Questionnaire
Bernstein, D. P., Stein, J. A., Newcomb, M. D., Walker, E., Pogge, D., Ahluvalia, T., Stokes, J., Handelsman, L., Medrano, M., Desmond, D., et al. (2003) · Child Abuse & Neglect · doi:10.1016/s0145-2134(02)00541-0 · Cited by 6,419
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Self-citationBagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90005-1 · Cited by 5,293
The Fifth Edition of the Addiction Severity Index.
Mclellan, A., Kushner, H., Metzger, D., Peters, R., Smith, I. E., Grissom, G. R., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,280
Cited by
Sorted by citations
Items 201–300 of 396
DeYoung, C. G., Blain, S. D., Latzman, R. D., Grazioplene, R. G., Haltigan, J. D., Kotov, R., Michelini, G., Venables, N. C., Docherty, A. R., Goghari, V. M., et al. (2023) · doi:10.31234/osf.io/yatw7 · Cited by 9
Chassin, L., & Sher, K. J. (2024) · Development and Psychopathology · doi:10.1017/s0954579424000671 · Cited by 9
Koudys, J. W., Cane, C., Nikolova, Y. S., & Ruocco, A. C. (2023) · Current Addiction Reports · doi:10.1007/s40429-023-00483-6 · Cited by 10
Zhao, Y., Skandali, N., Bethlehem, R. A. I., & Voon, V. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.03.008 · Cited by 8
Fede, S. J., Kisner, M. A., Manuweera, T., Kerich, M., & Momenan, R. (2022) · Alcohol and Alcoholism · doi:10.1093/alcalc/agac028 · Cited by 11
Self-citationJadhav, K. S., Jamot, B. B., Deroche‐Gamonet, V., Belin, D., & Boutrel, B. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15839 · Cited by 7
Oluwoye, O. A., Skalisky, J., Burduli, E., Chaytor, N. S., McPherson, S., Murphy, S. M., Herron, J. L., Hirchak, K. A., Burley, M. H., Ries, R. K., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.04.010 · Cited by 8
Zhao, J., Linn, B. K., Bradizza, C. M., Lucke, J. F., Ruszczyk, M. U., & Stasiewicz, P. R. (2020) · Alcohol and Alcoholism · doi:10.1093/alcalc/agaa138 · Cited by 7
Ramos, B. E. R., & Inozemtseva, O. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110816 · Cited by 7
Parlier‐Ahmad, A. B., Eglovitch, M., Legge, C., Keyser‐Marcus, L., Bjork, J. M., Adams, A., Ramey, T. S., Moeller, F. G., & Martin, C. E. (2023) · Brain and Behavior · doi:10.1002/brb3.3128 · Cited by 6
Chirokoff, V., Pohl, K. M., Berthoz, S., Fatseas, M., Misdrahi, D., Serre, F., Auriacombe, M., Pfefferbaum, A., Sullivan, E. V., & Chanraud, S. (2024) · Addiction Biology · doi:10.1111/adb.13400 · Cited by 6
Creswell, K. G., & Chung, T. A. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13846 · Cited by 7
Food addiction and self-regulation
Murphy, C. M., & MacKillop, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816207-1.00007-x · Cited by 7
A neurocognitive model of the comorbidity of substance use and personality disorders
Koudys, J. W., & Ruocco, A. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815298-0.00006-x · Cited by 10
Alcohol use disorder criteria exhibit different comorbidity patternsPreprint
Watts, A. L., Watson, D., Heath, A. C., & Sher, K. J. (2022) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/3fw2m · Cited by 7
Nieto, S. J., Grodin, E. N., & Ray, L. A. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.114926 · Cited by 6
Negative affectivity drivers of impulsivity in opioid use disorder
Vassileva, J., Psederska, E., & Bjork, J. M. (2025) · Nature Reviews Psychology · doi:10.1038/s44159-025-00404-6 · Cited by 6
Kurtin, D. L., Prabhu, A. M., Hassan, Q., Groen, A., Amer, M. J., Lingford-Hughes, A. R., & Paterson, L. M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106116 · Cited by 6
Subgroups of anxiety and depression trajectories during early abstinence in alcohol use disorder
Gopaldas, M., Flook, E. A., Hayes, N., Benningfield, M. M., & Blackford, J. U. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70032 · Cited by 6
Resources for the Assessment and Treatment of Substance Use Disorder in Adolescents
Pender, E., Kostak, L., Sutton, K., Naccarato, J. C., Tsai, A., Chung, T. A., & Daughters, S. B. (2023) · WikiJournal of Medicine · doi:10.15347/wjm/2023.001 · Cited by 6
Witkiewitz, K. A., Kirouac, M., Baurley, J. W., & McMahan, C. S. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15183 · Cited by 6
Paul, S. E., Baranger, D. A. A., Johnson, E. C., Jackson, J. J., Gorelik, A. J., Miller, A. P., Hatoum, A. S., Thompson, W. K., Strube, M., Dick, D. M., et al. (2024) · Psychological Medicine · doi:10.1017/s003329172400076x · Cited by 6
Chirokoff, V., Dupuy, M., Abdallah, M., Fatseas, M., Serre, F., Auriacombe, M., Misdrahi, D., Berthoz, S., Swendsen, J. D., Sullivan, E. V., et al. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100138 · Cited by 6
Everett, T. J., Eyck, T. W. T., Wu, C., Shelowitz, A. L., Stansbury, S. M., Firek, A., Setlow, B., & McIntyre, J. C. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231219058 · Cited by 6
Cannabis Use Disorder as a Developmental Disorder
Tomko, R. L., Williamson, A. N., McRae‐Clark, A. L., & Gray, K. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_18 · Cited by 6
Functional connectivity in resting-state fMRI (rs-fMRI) in opioid use disorder
Atanasova, N., Todeva-Radneva, A., Stoyanova, K., Psederska, E., Stoyanov, D., Traykova, N. I., & Vassileva, J. (2025) · The European Physical Journal Special Topics · doi:10.1140/epjs/s11734-025-01591-2 · Cited by 6
Cullins, E., Gunawan, T., Schwandt, M. L., Luk, J. W., George, D. T., Diazgranados, N., Goldman, D. A., & Ramchandani, V. A. (2025) · Addiction Biology · doi:10.1111/adb.70037 · Cited by 5
Self-citationHall, O. T., Gunawan, T., Teater, J. E., Bryan, C. J., Gorka, S. M., & Ramchandani, V. A. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2350057 · Cited by 5
The Therapeutic Effects of Classic Psychedelics in Alcohol Use Disorder
Pagni, B. A., Wong, J. M., & Bogenschutz, M. P. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00581-z · Cited by 6
Edemann-Callesen, H., Barak, S., Hadar, R., & Winter, C. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00316-w · Cited by 5
Common Factors Underlying Diverse Responses in Alcohol Use Disorder
Chebolu, E., Schwandt, M. L., Ramchandani, V. A., Stangl, B. L., George, D. T., Horneffer, Y. R., Vinson, T., Vogt, E. L., Manor, B. A., Diazgranados, N., et al. (2021) · Psychiatric Research and Clinical Practice · doi:10.1176/appi.prcp.20200028 · Cited by 5
Self-citationVassileva, J., Lee, J.-H., Psederska, E., & Ahn, W. (2023) · Neuromethods · doi:10.1007/978-1-0716-3230-7_14 · Cited by 5
Osuna, M. J. P., Herruzo, C., Lucena, V., Trenados, Y., & Herruzo, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1443289 · Cited by 6
Age dependent neural correlates of inhibition and control mechanisms in moderate to heavy drinkers
Swartz, M., Burton, F., Vakamudi, K., Al‐Khalil, K., Witkiewitz, K. A., & Claus, E. D. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102875 · Cited by 5
New approaches to deep phenotyping in addictionsPreprint
Watts, A. L., Latzman, R. D., Boness, C. L., Kotov, R., Keyser‐Marcus, L., DeYoung, C. G., Krueger, R. F., Zald, D. H., Moeller, F. G., & Ramey, T. (2022) · doi:10.31234/osf.io/9hdfn · Cited by 5
Independent, not irrelevant: Trial order causes systematic misestimation of economic choice traits.Preprint
Banavar, N. V., & Bornstein, A. M. (2023) · doi:10.31234/osf.io/a8gz3 · Cited by 5
Reilly, J., Meurk, C., Sara, G. E., & Heffernan, E. (2025) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674241312790 · Cited by 4
Li, W., Liu, J., Liu, X., Ge, Y., Wang, Y., & Zhang, A. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07378-y · Cited by 4
Tenekedjieva, L., McCalley, D. M., Goldstein‐Piekarski, A. N., Williams, L. M., & Padula, C. B. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.01.013 · Cited by 5
Sánchez, E., Cruz-Fuentes, C. S., Benjet, C. L., & Medina‐Mora, M. E. (2020) · Salud Mental · doi:10.17711/sm.0185-3325.2020.021 · Cited by 4
Lindenmuth, M., Herd, T., Brieant, A. E., Lee, J., Deater-Deckard, K. D., Bickel, W. K., King‐Casas, B., & Kim‐Spoon, J. (2022) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2022.101111 · Cited by 4
The Effects of Cognitive Impulsivity on the Duration of Remission in Alcohol-Dependent Patients
Алексеевич, Г. С. (2023) · Consortium Psychiatricum · doi:10.17816/cp13627 · Cited by 4
Neural response to threat and reward among young adults at risk for alcohol use disorder
Kirk‐Provencher, K. T., Hakimi, R. H., Andereas, K., Penner, A. E., & Gowin, J. L. (2024) · Addiction Biology · doi:10.1111/adb.13378 · Cited by 3
Chirokoff, V., Berthoz, S., Fatseas, M., Misdrahi, D., Dupuy, M., Abdallah, M., Serre, F., Auriacombe, M., Pfefferbaum, A., Sullivan, E. V., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02949-1 · Cited by 4
Meruelo, A. D., Gunawan, T., Thomas, M. L., & Ramchandani, V. A. (2024) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2024.101471 · Cited by 4
Effects of Alcohol on EEG Activity: A Systematic Review Focused on Sex-Related Differences in Youth
Elliott, A. S., Moreno‐Fernández, R. D., & Sampedro‐Piquero, P. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241106095027 · Cited by 4
Nikolova, Y. S., Ruocco, A. C., Felsky, D., Lange, S., Prévot, T. D., Vieira, É. L. M., Voineskos, D., Wardell, J. D., Blumberger, D. M., Clifford, K. P., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1455968 · Cited by 6
Litten, R. Z. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13222 · Cited by 4
Self-citationJoyner, K. J., Yancey, J. R., Venables, N. C., Burwell, S. J., Iacono, W. G., & Patrick, C. J. (2021) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2021.02.017 · Cited by 4
Hazardous drinking and alcohol use disorders
(2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00414-1 · Cited by 4
Joyner, K. J., Patrick, C. J., Morris, D. H., McCarthy, D. M., & Bartholow, B. D. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01874-7 · Cited by 5
Dissecting compulsive eating behavior into three elements
Moore, C. F., Sabino, V., Koob, G. F., & Cottone, P. (2019) · Compulsive Eating Behavior and Food Addiction · doi:10.1016/b978-0-12-816207-1.00003-2 · Cited by 4
Self-citationWeidacker, K., Kim, S., Callesen, M. B., Jensen, M., Pedersen, M. U., Thomsen, K. R., & Voon, V. (2020) · Psychological Medicine · doi:10.1017/s0033291720003852 · Cited by 6
Lauvsnes, A. D. F., Hansen, T. I., Haberg, A. K., Gråwe, R. W., & Langaas, M. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2091788 · Cited by 4
Tomko, R. L., & McClure, E. A. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.04.004 · Cited by 4
Editorial: Brain and Cognition for Addiction Medicine: From Prevention to Recovery
Ekhtiari, H., Verdejo‐García, A., Moeller, S. J., Zare-Bidoky, M., Baldacchino, A., & Paulus, M. P. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.590030 · Cited by 4
Elsayed, M., Belisario, K. L., Murphy, J. G., & MacKillop, J. M. (2026) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn-25-0116 · Cited by 3
Neurobiology of negative reinforcement as a driving force in alcohol addiction
Vendruscolo, L. F., & Koob, G. F. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.038 · Cited by 4
Self-citationModeling social cognition in alcohol use disorder: lessons from schizophrenia
Perini, I., Pabst, A., Martínez, D., Maurage, P., & Heilig, M. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06601-0 · Cited by 3
Early Life Adversity as a Risk Factor for Alcohol Use Disorder
Schwandt, M. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_34 · Cited by 3
Sleep Deficiency and Opioid Use Disorder
Langstengel, J., & Yaggi, H. K. (2024) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2024.07.009 · Cited by 3
Miguel, A. C., Smith, C. L., Perea, N. M., Johnson, R. K., McDonell, M. G., & McPherson, S. (2021) · JMIR Formative Research · doi:10.2196/25796 · Cited by 3
Neuropsychology in GD: old and new directions
Balodis, I. M. (2019) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2019.11.002 · Cited by 3
Socio-Emotional Deficits in Severe Alcohol Use Disorders
Maurage, P., Rolland, B., & D’Hondt, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813125-1.00039-8 · Cited by 3
Genetic Influences on Alcohol Sensitivity: a Critical Review
Yeung, E. W., Herchenroeder, L., Webster, H., Albright, A. B., & Gizer, I. R. (2023) · Current Addiction Reports · doi:10.1007/s40429-023-00530-2 · Cited by 2
Segrin, C. G., Jiao, J., & Cooper, R. A. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2024.2383615 · Cited by 2
Garber, M. L., & MacKillop, J. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02257-2 · Cited by 3
Bolt, G. L., Rowland, B., Piercy, H., Bradshaw, J., Lubman, D. I., & Manning, V. (2025) · Addictive Behaviors · doi:10.1016/j.addbeh.2025.108560 · Cited by 3
Oliveras, C., Balcells-Oliveró, M., Bataller, R., Bruguera, P., Cabrera, N., Calomarde-Gómez, C., Caballería, E., Freixa, N., García-Pañella, O., Gratacós‐Ginès, J., et al. (2026) · Liver International · doi:10.1111/liv.70506 · Cited by 2
Kennedy, T. M., Wang, F. L., Molina, B. S. G., Williard, A., & Pedersen, S. L. (2026) · Current Addiction Reports · doi:10.1007/s40429-025-00708-w · Cited by 3
Makarewicz, A., Recław, R., Grzywacz, A., Chmielowiec, J., & Chmielowiec, K. (2026) · Brain Sciences · doi:10.3390/brainsci16020187 · Cited by 2
Assessment of cognitive functions in individuals with substance use disorder and HIV
Vetrova, M., Krupitsky, E. M., Trusova, A. V., Георгиевна, К. С., Белова, О. Г., Borovskaya, V. G., Irkhina, M. D., Ponomarev, E. R., Toussova, O., & Blokhina, E. A. (2022) · HIV Infection and Immunosuppressive Disorders · doi:10.22328/2077-9828-2021-13-4-21-32 · Cited by 2
Addictions Neuroclinical Assessment
Gunawan, T., Kwako, L. E., Diazgranados, N., Koob, G. F., Goldman, D. A., & Ramchandani, V. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_14 · Cited by 3
Self-citationTreatment Failure Versus Failed Treatments: The Risks of Embracing Treatment Refractory Addiction
Fiellin, D. A. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001351 · Cited by 2
Eckhardt, C. I., & Parrott, D. J. (2024) · Psychology of Violence · doi:10.1037/vio0000558 · Cited by 2
Jett, J. D., Tyutyunnyk, D., Beck, R., Palmer, K., Ryan, D., Sanchez, J. J., Weeks, D. L., McPherson, S., Chaytor, N. S., Kiluk, B. D., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.107807 · Cited by 4
Substance use disorders: a call for a staging paradigm
Bachi, K., Hurd, Y. L., & Salsitz, E. A. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03484-3 · Cited by 2
An Integrative Biobehavioral Trait Perspective on Antisocial Personality Disorder and Psychopathy
Brislin, S. J., & Patrick, C. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108333931.045 · Cited by 3
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-816988-9.00001-1 · Cited by 2
Self-citationBuilding Models of Psychopathology Spanning Multiple Modalities of Measurement
Venables, N. C., & Patrick, C. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316995808.004 · Cited by 1
Stage-Based Treatment Approaches for Substance Use Disorders
Mancini, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-59659-0_11 · Cited by 3
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816863-9.00002-9 · Cited by 2
Self-citationBoness, C. L. (2021) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/90983 · Cited by 2
Nikolova, Y. S., Ruocco, A. C., Felsky, D., Lange, S., Prévot, T. D., Vieira, É. L. M., Voineskos, D., Wardell, J. D., Blumberger, D. M., Clifford, K. P., et al. (2024) · medRxiv · doi:10.1101/2024.08.30.24312806 · Cited by 2
FONG, T. W. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb05 · Cited by 1
Initial Validation of a Behavioral Phenotyping Model for Substance Use Disorder
Keyser‐Marcus, L., Ramey, T., Bjork, J. M., Martin, C. E., Sabo, R. T., & Moeller, F. G. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21010014 · Cited by 1
Drug Abuse & Cognitive Functioning
Nautiyal, A. (2023) · Mental Health & Human Resilience International Journal · doi:10.23880/mhrij-16000227 · Cited by 1
Compulsivity and Impulsivity Dimensions as Familial Neurocognitive Markers of Heroin Addiction
Vassileva, J., & Psederska, E. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.12.005 · Cited by 1
Rubio, G., Marín, M., Arroba, C. M., Rubio-Escobar, E., Árias, F., Torregrosa, A. B., & Manzanares, J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1613169 · Cited by 1
Toward a Neurocounseling Paradigm: The Science Behind Step One in Addiction Recovery
Ashton, C., & Duffie, D. (2025) · Global Journal of Medical Research · doi:10.34257/gjmravol25is1pg17 · Cited by 1
Hammond, C. J., Ma, L., Bjork, J. M., Moeller, F. G., & Arias, A. J. (2025) · Brain Structure and Function · doi:10.1007/s00429-025-02992-8 · Cited by 1
Disrupted decision making in adult male rats after prolonged withdrawal from ethanol vapor exposure
Cheng, Y., Kalapatapu, N., & Janak, P. H. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70143 · Cited by 1
Cofresí, R. U., Keerstock, S., Kohen, C. B., Piasecki, T. M., & Bartholow, B. D. (2025) · Addiction · doi:10.1111/add.70247 · Cited by 2
Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials
McManus, K. R., & Ray, L. A. (2026) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2026.2625341 · Cited by 2
Grodin, E. N., Kirsch, D. E., Baskerville, W., & Ray, L. A. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113084 · Cited by 2
Utredning av kognitiv fungering i tverrfaglig spesialisert rusbehandling
Erga, A. H., Hetland, J. G., Høiland, K., Fodstad, E. C., Drevsjø, S., & Braatveit, K. J. (2026) · Tidsskrift for Norsk psykologforening · doi:10.52734/mdgw7844 · Cited by 1
Behavioral phenotypes associated with cannabis and alcohol substitution
Pince, C. L., Piercey, C. J., Stallsmith, V. T., Weldon, K., Ruehrmund, J., Dooley, G., & Karoly, H. C. (2026) · Harm Reduction Journal · doi:10.1186/s12954-026-01432-y · Cited by 1
Garber, M. L., McIntyre‐Wood, C., Elsayed, M., Amlung, M. T., Sweet, L. H., & MacKillop, J. M. (2026) · Addiction · doi:10.1111/add.70371 · Cited by 1
Xu, X., & Dong, G.-H. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111695 · Cited by 1
Neurobiological and psychosocial correlates of problematic social media use: an addiction framework
Shannon, H., Montgomery, M., Bush, K., Griffiths, M. D., Stead, J., Lemieux, M., Guimond, S., & Hellemans, K. G. C. (2026) · Addiction Research & Theory · doi:10.1080/16066359.2026.2650300 · Cited by 1
Metadata
- Authors
- Kwako, L. E., Momenan, R., Litten, R. Z., Koob, G. F., & Goldman, D.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Kwako, Laura E.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 80
- Issue
- 3
- Pages
- 179-189
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC4870153
- OpenAlex
- W2207035985
- Semantic Scholar
- 621a35dbbd45d7e898e2999389a1fe6c88ac4688
- Cited by
- 395
- References
- 151
- Citations by year
- 2026: 48 · 2025: 32 · 2024: 46 · 2023: 38 · 2022: 43 · 2021: 47 · 2020: 38 · 2019: 46 · 2018: 24 · 2017: 27 · 2016: 6
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99‐AA999999)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- addiction, executive function, incentive salience, negative affectivity, addiction classification, Research Domain Criteria, neuroimaging, clinical heterogeneity, causes of addiction
- MeSH terms
- Emotions, Humans, Models, Psychological, Motivation, Neuropsychological Tests, Behavior, Addictive, Substance-Related Disorders, Executive Function, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
